Stem Cell Ophthalmology Treatment Study II (SCOTS 2)

SCOTS is the only stem cell study into which patients can enroll, which has actual published, statistically significant results in certain eye diseases.

New publications and statistical verification of results continue to be added with data collected from both the original SCOTS and now SCOTS II. Please see our Medical Journals results page.

What is the actual treatment?

Patients typically receive 2 separate injections of bone marrow-derived stem cells for each affected eye, followed by intravenous bone marrow-derived stem cells. The procedure is performed as an outpatient at the ParkCreek Surgery Center under general or MAC anesthesia by board-certified anesthesiologists. Bone marrow aspiration is painless and performed by our board-certified orthopedic surgeon.

Treatment is provided by our board-certified and fellowship-trained retinal surgeon. A minimum 3-night stay is required in the area to allow a preop day, procedure day, and postop visit. Patients may return home the postop day, and flying is perfectly fine. Cost is typically USD $19,600.00 but can be as much as USD $21,600 for the most complex procedure. See NCT 03011541